The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial

Liatsikos K., Hyder-Wright A., Davies K., El Safadi D., Farrar M., Goncalves A., Gonzalez-Dias P., Gordon SB., Howard A., Lesosky M., Liu X., Mitsi E., Myerscough C., Nyazika TK., Pollard AJ., Reiné J., Robinson RE., Solórzano C., Urban BC., Zhang Y., Lahuerta M., Theilacker C., Catusse J., Begier E., Tan Y., Jodar L., Gessner BD., Collins A., Ferreira DM.

DOI

10.1016/j.lanmic.2025.101267

Type

Journal article

Publisher

Elsevier BV

Publication Date

2026-02-01T00:00:00+00:00

Pages

101267 - 101267

Total pages

0

Permalink More information Close